Abstract
The corneal epithelium is one of the major structures that undergo changes to the ocular surface. It is for this reason that the central epithelial thickness measurement has been proposed as an objective indicator to monitor the health of the ocular surface. We report the case of a 60-year-old patient who has bilateral open-angle glaucoma under dual therapy and diffuse bilateral central epithelial thinning in epithelial mapping. Thickness variability can be correlated with patientÂ’s dry eye symptoms, and that epithelial thickness profiles could be used to monitor a patients response to treatment. The thinning is usually moderate and its exact therapeutic implication in terms of stopping or changing therapy remains to be determined by future studies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
